• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation.

作者信息

Wüthrich R P, Weinreich T, Schwarzkopf A K, Candinas D, Binswanger U

机构信息

Division of Nephrology, University Hospital, Zürich, Switzerland.

出版信息

Transplant Proc. 1998 Dec;30(8):4096-7. doi: 10.1016/s0041-1345(98)01355-4.

DOI:10.1016/s0041-1345(98)01355-4
PMID:9865310
Abstract
摘要

相似文献

1
Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation.与传统的硫唑嘌呤方案相比，基于霉酚酸酯的三联免疫抑制疗法的上市后评估显示，肾移植后疗效增强且具有早期药物经济学效益。
Transplant Proc. 1998 Dec;30(8):4096-7. doi: 10.1016/s0041-1345(98)01355-4.
2
Triple therapy with mycophenolate mofetil versus azathioprine.
Transplant Proc. 1999 Feb-Mar;31(1-2):1144-6. doi: 10.1016/s0041-1345(98)01939-3.
3
Mycophenolate mofetil eliminates the rationale for antilymphocyte induction therapy in nonhaploidentical living-donor kidney transplants.霉酚酸酯消除了非单倍体活体供肾移植中抗淋巴细胞诱导治疗的理论依据。
Transplant Proc. 1997 Feb-Mar;29(1-2):342-3. doi: 10.1016/s0041-1345(96)00300-4.
4
Mycophenolate mofetil for the prevention of acute rejection of primary cadaveric kidney transplants: status of the MYC 1866 study at 1 year. The U.S. Mycophenolate Mofetil Study Group.
Transplant Proc. 1997 Feb-Mar;29(1-2):348-9. doi: 10.1016/s0041-1345(96)00302-8.
5
Triple therapy with mycophenolate mofetil, cyclosporine, and prednisone in renal transplantation.
Transplant Proc. 1999 Sep;31(6):2261-2. doi: 10.1016/s0041-1345(99)00329-2.
6
Pharmacoeconomic analysis of mycophenolate mofetil versus azathioprine in primary cadaveric renal transplantation.
Transplant Proc. 1998 Dec;30(8):4082-4. doi: 10.1016/s0041-1345(98)01349-9.
7
Selective CellCept therapy in high-risk renal transplant recipients.
Transplant Proc. 1998 Jun;30(4):1188-9. doi: 10.1016/s0041-1345(98)00202-4.
8
Mycophenolate mofetil as maintenance immunosuppression in pediatric renal transplantation.
Transplant Proc. 1997 Feb-Mar;29(1-2):340-1. doi: 10.1016/s0041-1345(96)00296-5.
9
Reduced kidney transplant rejection rate and pharmacoeconomic advantage of mycophenolate mofetil.霉酚酸酯降低肾移植排斥反应率及具有药物经济学优势。
Nephrol Dial Transplant. 1999 Feb;14(2):394-9. doi: 10.1093/ndt/14.2.394.
10
Mycophenolate mofetil in ongoing chronic kidney allograft dysfunction.
Transplant Proc. 1998 Dec;30(8):4075-6. doi: 10.1016/s0041-1345(98)01346-3.

引用本文的文献

1
Intragraft transcriptional profiling of renal transplant patients with tubular dysfunction reveals mechanisms underlying graft injury and recovery.对患有肾小管功能障碍的肾移植患者进行移植物内转录谱分析，揭示了移植物损伤和恢复的潜在机制。
Hum Genomics. 2016 Jan 7;10:2. doi: 10.1186/s40246-015-0059-6.
2
Mycophenolate mofetil: a pharmacoeconomic review of its use in solid organ transplantation.霉酚酸酯：对其在实体器官移植中应用的药物经济学综述
Pharmacoeconomics. 2002;20(10):675-713. doi: 10.2165/00019053-200220100-00004.